182133-27-3

Treatment of symptoms associated with uterine fibroids, endometriosis, and dysfunctional uterine bleeding; in the treatment of estrogen receptor positive recurrent/metastatic breast cancer; as an adjuvant to breast cancer therapy (selective estrogen recep.